Select language:  
1800 620 420
Close menu

PhD scholarships focused on improving outcomes for people with AML and MPN

Basit Salik, Dr Jamie Kuzich and Dr Julian Grabek are the successful recipients of the 2021 PhD Scholarships.

  • Acute myeloid leukaemia
  • Myeloproliferative neoplasms
  • Research
Read more
Illustration of a microscope, test tubes, and clipboard

Chronic blood cancer diagnosis sparks Mel’s passion for awareness

Since receiving a shock CML diagnosis in July 2020, Mel Harris has learnt quickly that the so-called ‘invisible cancer’ can have everyday impacts beyond what many would expect.

  • Chronic myeloid leukaemia
Read more
Mel Harris

Oren fast-tracked to CAR T-cell therapy for rare Ph-like ALL

Sports-lover Oren was only the sixth child in Australia to receive CAR T-cell treatment.

  • Acute lymphoblastic leukaemia
Read more
Oren stands outside, smiling

Osher Gunsberg shines a light on blood cancer and hosts Australia’s first virtual Light the Night event

  • Media releases
  • Our supporters
Read more
osher-light-the-night-blood-cancer

National Action Plan represents Australian first opportunity to achieve zero lives lost to blood cancer by 2035

  • Advocacy and policy
  • Media releases
Read more

Same cancer, same drug but our access to treatment was anything but consistent

They’re three women all battling an incurable type of blood cancer, but Neda, Nikki and Shirley have felt hardship in very different ways.

  • Myeloma
Read more
Neda Masters

I needed better information about clinical trial options

Matthew Fogarty has spent almost five years regularly travelling to the other side of the world to collect the handful of pills that keep his blood cancer at bay.

  • Clinical trials
  • Other blood cancers
Read more
Matthew Fogarty

I took control after becoming adrift in the system

The long wait for a diagnosis took its toll on Bronwyn Bisley, but her biggest challenges lay ahead as the information she desperately needed dried up.

  • Hodgkin lymphoma
Read more
Bronwyn Bisley

Personalised cellular therapy gives Hunter a future

A cutting-edge cellular therapy, made possible by breakthrough research, has given seven-year-old Hunter hope for a brighter future.

  • Acute lymphoblastic leukaemia
Read more
The Madden Family

Drug discovery has remarkable potential for high-risk childhood leukaemia

Dr Michelle Henderson's research is laying the groundwork to develop a promising new therapy for infant ALL.

  • Acute lymphoblastic leukaemia
  • Research
Read more
Dr Michelle Henderson in the lab